Effects of resveratrol, a grape polyphenol, on uterine contraction and Ca2+ mobilization in rats in vivo and in vitro

Endocrinology

Volumn 152, Issue 5, 2011, Pages 2090-2099

  Hsia, Shih Min ^a   Wang, Kai Lee ^b   Wang, Paulus S ^b,c,d  

^a KAINAN UNIVERSITY   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c TAIPEI CITY HOSPITAL   (Taiwan)

^d Department of Medical Research and Education   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIHYDRO 2,6 DIMETHYL 5 NITRO 4 [2 (TRIFLUOROMETHYL)PHENYL] 3 PYRIDINECARBOXYLIC ACID METHYL ESTER; ACETYLCHOLINE; CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; CARBACHOL; OXYTOCIN; POTASSIUM CHLORIDE; PROSTAGLANDIN F2 ALPHA; RESVERATROL;

ANIMAL EXPERIMENT; ARTICLE; CALCIUM MOBILIZATION; CALCIUM TRANSPORT; CELL MEMBRANE DEPOLARIZATION; CONTROLLED STUDY; DRUG INHIBITION; FEMALE; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE CONTRACTION; UTERUS CONTRACTION;

ACETYLCHOLINE; ANIMALS; CALCIUM; CARBACHOL; CELLS, CULTURED; DINOPROST; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FLAVONOIDS; HUMANS; MALE; MYOCYTES, SMOOTH MUSCLE; MYOSIN LIGHT CHAINS; OXYTOCICS; OXYTOCIN; PHENOLS; PHOSPHORYLATION; PREGNANCY; RATS; RATS, SPRAGUE-DAWLEY; STILBENES; UTERINE CONTRACTION; UTERUS; VASODILATOR AGENTS; VITIS;

EID: 79955431007     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2010-1223     Document Type: Article

References (44)

1. Klein JR, Litt IF, Rosenberg A, Udall L 1981 The effect of aspirin on dysmenorrhea in adolescents. J Pediatr 98:987-990 (Pubitemid 11093071)
2. Harlow SD, Park M 1996 A longitudinal study of risk factors for the occurrence, duration and severity of menstrual cramps in a cohort of college women. Br J Obstet Gynaecol 103:1134-1142 (Pubitemid 26371063)
3. Jamieson DJ, Steege JF 1996 The prevalence of dysmenorrhea, dyspareunia, pelvic pain, and irritable bowel syndrome in primary care practices. Obstet Gynecol 87:55-58 (Pubitemid 26015951)
4. Chen C, Cho SI, Damokosh AI, Chen D, Li G, Wang X, Xu X 2000 Prospective study of exposure to environmental tobacco smoke and dysmenorrhea. Environ Health Perspect 108:1019-1022
5. Hirata M, Kumabe K, Inoue y 2002 Relationship between the frequency of menstrual pain and bodyweight in female adolescents. Nippon Koshu Eisei Zasshi 49:516-524
6. Chiou MH, Wang HH 2008 Predictors of dysmenorrhea and selfcare behavior among vocational nursing school female students. J Nurs Res 16:17-25
7. Rosenwaks Z, Jones GS, Henzl MR, Dubin NH, Ghodgaonkar RB, Hoffman S 1981 Naproxen sodium, aspirin, and placebo in primary dysmenorrhea. Reduction of pain and blood levels of prostaglandin F2-α metabolite. Am J Obstet Gynecol 140:592-598 (Pubitemid 11093143)
8. Proctor ML, Murphy PA, Pattison HM, Suckling J, Farquhar CM 2007 Behavioural interventions for primary and secondary dysmenorrhea. Cochrane Database Syst 3: CD002248
9. Proctor ML, Farquhar CM 2006 Dysmenorrhoea. Clin Evid 15:2429-2448
10. Dawood MY, Khan-Dawood FS 2007 Differential suppression of menstrual fluid prostaglandin F2a, prostaglandin E2,6-keto prostaglandin F1a and thromboxane B2 by suprofen in women with primary dysmenorrhea. Prostaglandins Other Lipid Mediat 83:146-153 (Pubitemid 46149409)
11. Dawood MY, Khan-Dawood FS 2007 Clinical efficacy and differential inhibition of menstrual fluid prostaglandin F2α in a randomized, double-blind, crossover treatment with placebo, acetaminophen, and ibuprofen in primary dysmenorrhea. Am J Obstet Gynecol 196:35.e1-5
12. Bertelli AA, Das DK 2009 Grapes, wines, resveratrol, and heart health. J Cardiovasc Pharmacol 54:468-476
13. Burns J, Yokota T, Ashihara H, Lean ME, Crozier A 2002 Plant foods and herbal sources of resveratrol. J Agric Food Chem 50:3337-3340 (Pubitemid 34533643)
14. Kroon PA, Iyer A, Chunduri P, Chan V, Brown L 2010 The cardiovascular nutrapharmacology of resveratrol: pharmacokinetics, molecular mechanisms and therapeutic potential. Curr Med Chem 17:2442-2455
15. Djoko B, Chiou RY, Shee JJ, Liu YW 2007 Characterization of immunological activities of peanut stilbenoids, arachidin-1, piceatannol, and resveratrol on lipopolysaccharide-induced inflammation of RAW 264.7 macrophages. J Agric Food Chem 55:2376-2383 (Pubitemid 46556227)
16. Hudson TS, Hartle DK, Hursting SD, Nunez NP, Wang TT, Young HA, Arany P, Green JE 2007 Inhibition of prostate cancer growth by muscadine grape skin extract and resveratrol through distinct mechanisms. Cancer Res 67:8396-8405 (Pubitemid 47395179)
17. Hung LM, Su MJ, Chu WK, Chiao CW, Chan WF, Chen JK 2002 The protective effect of resveratrols on ischaemia-reperfusion injuries of rat hearts is correlated with antioxidant efficacy. Br J Pharmacol 135:1627-1633
18. Lee MH, Choi BY, Kundu JK, Shin YK, Na HK, Surh YJ 2009 Resveratrol suppresses growth of human ovarian cancer cells in culture and in a murine xenograft model: eukaryotic elongation factor 1A2 as a potential target. Cancer Res 69:7449-7458
19. Ramprasath VR, Jones PJ 2010 Anti-atherogenic effects of resveratrol. Eur J Clin Nutr 64:660-668
20. Xia EQ, Deng GF, Guo YJ, Li HB 2010 Biological activities of polyphenols from grapes. Int J Mol Sci 11:622-646
21. Hsia SM, Kuo YH, Chiang W, Wang PS 2008 Effects of adlay hull extracts on uterine contraction and Ca2 + mobilization in the rat. Am J Physiol Endocrinol Metab 295: E719-E726
22. Grynkiewicz G, Poenie M, Tsien RY 1985 A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem 260:3440-3450 (Pubitemid 15114340)
23. Ikeda S, Tamaoki H 1984 Pharmacological investigation of ritodrine hydrochloride, a β 2-adrenoceptor stimulant. Jpn J Pharmacol 36:477-484 (Pubitemid 15186386)
24. Ikeda S, Tamaoki H, Akahane M, Nebashi y 1984 Effects of ritodrine hydrochloride, a β 2-adrenoceptor stimulant, on uterine motilities in late pregnancy. Jpn J Pharmacol 35:319-326 (Pubitemid 14124826)
25. Ruttner Z, Ivanics T, Slaaf DW, Reneman RS, Toth A, Ligeti L 2002 In vivo monitoring of intracellular free calcium changes during uterine activation by prostaglandin f (2α) and oxytocin. J Soc Gynecol Investig 9:294-298 (Pubitemid 35292298)
26. Ansari HR, Husain S, Abdel-Latif AA 2001 Activation of p42/p44 mitogen-activated protein kinase and contraction by prostaglandin F2α, ionomycin, and thapsigargin in cat iris sphincter smooth muscle: inhibition by PD98059, KN-93, and isoproterenol. J Pharmacol Exp Ther 299:178-186 (Pubitemid 32905133)
27. Calesnick B, Dinan AM 1987 Prostaglandins and NSAIDs in primary dysmenorrhea. Am Fam Physician 35:223-225 (Pubitemid 17006497)
28. Harel Z 2004 Cyclooxygenase-2 specific inhibitors in the treatment of dysmenorrhea. J Pediatr Adolesc Gynecol 17:75-79 (Pubitemid 38406017)
29. Ayar A 2007 Tocolytic effect of parecoxib, a new parenteral cyclooxygenase-2-specific inhibitor, on the spontaneous and prostaglandin- induced contractions of rat isolated myometrium. Clin Exp Pharmacol Physiol 34:737-741 (Pubitemid 47013487)
30. Sperelakis N, Inoue Y, Ohya y 1992 Fast Na+ channels and slow Ca2+ current in smooth muscle from pregnant rat uterus. Mol Cell Biochem 114:79-89
31. Gojkovic-Bukarica L, Novakovic A, Kanjuh V, Bumbasirevic M, Lesic A, Heinle H 2008 A role of ion channels in the endotheliumindependent relaxation of rat mesenteric artery induced by resveratrol. J Pharmacol Sci 108:124-130
32. Naderali EK, Doyle PJ, Williams G 2000 Resveratrol induces vasorelaxation of mesenteric and uterine arteries from female guineapigs. Clin Sci 98:537-543 (Pubitemid 30261002)
33. Wang LD, Qiu XQ, Tian ZF, Zhang YF, Li HF 2008 Inhibitory effects of genistein and resveratrol on guinea pig gallbladder contractility in vitro. World J Gastroenterol 14:4955-4960
34. Ikebe M, Hartshorne DJ, Elzinga MI 1985 Phosphorylation of smooth muscle myosin at two distinct sites by myosin light chain kinase. J Biol Chem 260:10027-10031 (Pubitemid 16244088)
35. Ito M, Nakano T, Erdodi F, Hartshorne DJ 2004 Myosin phosphatase: structure, regulation and function. Mol Cell Biochem 2004 259:197-209 (Pubitemid 38519232)
36. Reagan-Shaw S, Nihal M, Ahmad N 2008 Dose translation from animal to human studies revisited. FASEB J 22:659-661 (Pubitemid 351348146)
37. Frémont L 2000 Biological effects of resveratrol. Life Sci 66:663-673
38. Bertelli AE, Giovannini, L, Stradi R, Urien S 1996 Kinetics of transand cis-resveratrol (3,4′,5-trihydroxystilbene) after red wine oral administration to rats. Int J Clin Pharm Res 16:77-81
39. Lee B, Moon SK 2005 Resveratrol inhibits TNF-α-induced proliferation and matrix metalloproteinase expression in human vascular smooth muscle cells. J Nutr 135:2767-2773 (Pubitemid 43156539)
40. Kimura Y, Okuda H 2001 Resveratrol isolated from Polygonum cuspidatum root prevents tumor growth and metastasis to lung and tumor-induced neovascularization in Lewis lung carcinoma-bearing mice. J Nutr 131:1844-1849 (Pubitemid 32520456)
41. Wong DH, Villanueva JA, Cress AB, Duleba AJ 2010 Effects of resveratrol on proliferation and apoptosis in rat ovarian theca-interstitial cells. Mol Hum Reprod 16:251-259
42. Bertelli AA, Giovannini L, Stradi R, Bertelli A, Tillement JP 1996 Plasma, urine and t issue levels of trans-and cis-resveratrol (3,4′,5-trihydroxystilbene) after short-term or prolonged administration of red wine to rats. Int J Tissue React 18:67-71
43. Bertelli A, Bertelli AA, Gozzini A, Giovannini L 1998 Plasma and tissue resveratrol concentrations and pharmacological activity. Drugs Exp Clin Res 24:133-138 (Pubitemid 28499568)
44. Walle T, Hsieh F, DeLegge MH, Oatis Jr JE, Walle UK 2004 High absorption but very low bioavailability of oral resveratrol in humans. Drug Metab Dispos 32:1377-1382 (Pubitemid 39564557)